Clinical Trial Update: Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device

View source ↗

Summary

The postmarket clinical follow-up study of the Arcadius XP L interbody fusion device has been withdrawn, with listed indications including chronic low back pain…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Low Back Pain
• Postdiscectomy Syndrome
• Posttraumatic Instability
• Spondylolysis

Snippet

Sponsor: Aesculap AG | Conditions: Chronic Low-back Pain, Degenerative Disc Disease | Status: WITHDRAWN